| __timestamp | Regeneron Pharmaceuticals, Inc. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2819557000 | 28203205 |
| Thursday, January 1, 2015 | 4103728000 | 99892000 |
| Friday, January 1, 2016 | 4860427000 | 133591000 |
| Sunday, January 1, 2017 | 5872227000 | 154937000 |
| Monday, January 1, 2018 | 6710800000 | 164246000 |
| Tuesday, January 1, 2019 | 7863400000 | 175338000 |
| Wednesday, January 1, 2020 | 8497100000 | 198321000 |
| Friday, January 1, 2021 | 16071700000 | 227490000 |
| Saturday, January 1, 2022 | 12172900000 | 212018000 |
| Sunday, January 1, 2023 | 13117200000 | 145238000 |
| Monday, January 1, 2024 | 14202000000 |
Cracking the code
In the competitive world of biotechnology, revenue growth is a key indicator of a company's success. Over the past decade, Regeneron Pharmaceuticals, Inc. has consistently outperformed Travere Therapeutics, Inc. in terms of revenue generation. From 2014 to 2023, Regeneron's revenue surged by approximately 365%, peaking in 2021 with a remarkable 470% increase compared to its 2014 figures. In contrast, Travere Therapeutics experienced a more modest growth of around 415% during the same period, with its highest revenue recorded in 2021.
Regeneron's strategic focus on innovative therapies has propelled its financial success, while Travere's niche approach in rare diseases has shown steady, albeit slower, growth. This data highlights the diverse strategies within the biotech sector and underscores the importance of innovation and market positioning in driving revenue growth.
Eli Lilly and Company vs Regeneron Pharmaceuticals, Inc.: Examining Key Revenue Metrics
AbbVie Inc. vs Regeneron Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Gilead Sciences, Inc. or Regeneron Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Regeneron Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Annual Revenue Comparison: Regeneron Pharmaceuticals, Inc. vs Mesoblast Limited
Genmab A/S or Travere Therapeutics, Inc.: Who Leads in Yearly Revenue?
Corcept Therapeutics Incorporated and Travere Therapeutics, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: Cytokinetics, Incorporated and Travere Therapeutics, Inc. Performance Compared
Revenue Showdown: TG Therapeutics, Inc. vs Travere Therapeutics, Inc.
Who Generates More Revenue? Dynavax Technologies Corporation or Travere Therapeutics, Inc.
Who Generates More Revenue? Travere Therapeutics, Inc. or Celldex Therapeutics, Inc.
Travere Therapeutics, Inc. and Viridian Therapeutics, Inc.: A Comprehensive Revenue Analysis